BioSpace News Archive

Washington Hospital Healthcare System is the recipient of a three-year grant totaling $500,000 to support its expansion of palliative care services to outpatients.

The 17th Annual Parkway Run & Walk presented by Citadel raised a record-breaking $1.5 million to support childhood cancer research and care at Children’s Hospital of Philadelphia.

Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma) (Hong Kong Stock Exchange: 2607) (Shanghai Stock Exchange: 601607) has launched a new stock incentive plan (the Plan) aligned with international standards aimed at retaining and attracting talent while propelling the Chinese healthcare conglomerate into a world-class pharmaceutical innovator.

Today the Accreditation Council for Graduate Medical Education (ACGME) released its 2018-2019 Data Resource Book, the most comprehensive and reliable resource of its kind, including data on the size, scope, and distribution of graduate medical education (GME) in the U.S.

Synlogic, Inc. (NASDAQ: SYBX) announced today that Aoife Brennan, M.B., B.Ch., Synlogic’s president and chief executive officer, will provide a corporate update at the Chardan 3rd Annual Genetic Medicines Conference on Monday, October 7 at 4:15 pm ET, in New York City.

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, announced today the completion of enrollment for the Phase 3 PolarisDMD trial of edasalonexent in Duchenne muscular dystrophy (DMD).

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its newly enhanced GeneGlobe Design & Analysis Hub, bringing next-level experiment planning, execution and follow-up to life science researchers.

McKesson Corporation (NYSE:MCK) announced today that its second quarter fiscal 2020 financial results will be released before market open on Wednesday, October 30, 2019.

ACUVUE™ RevitaLens MPDS Delivers Exceptional Contact Lens Disinfection and All-Day Comfort [30-September-2019] JACKSONVILLE, Fla. , Sept. 30, 2019 /PRNewswire/ -- Johnson & Johnson Vision † is excited to unveil the first-ever extension of the ACUVUE ® brand name beyond contact lenses with today’s launch of ACUVUE™ RevitaLens Multi-Purpose Disinfecting Solution (MP

Boehringer Ingelheim announced that in the Phase III INBUILD® trial Ofev® slowed lung function decline by 57% across the overall study population, as assessed by the annual rate of decline in forced vital capacity over 52 weeks in patients with fibrosing interstitial lung diseases with signs of progression.